Increasing Awareness Around the Genetic Components of ALS

Jennifer Roggenbuck, MS, LGC, opens a discussion on patient journeys with ALS.

Laynie Dratch, ScM, CGC, discusses the prognosis associated ALS.

Key humanistic burdens, including stressors on patients and family members, are highlighted.

Medical experts provide insights on the impact of delayed treatment interventions for patients diagnosed with ALS.

Genetic testing for family members of patients diagnosed with ALS can provide opportunities for early awareness and disease intervention.

Jennifer Roggenbuck, MS, LGC, and Laynie Dratch, ScM, CGC, discuss common genetic mutations associated with ALS.

Experts discuss the driving factors behind costs within the treatment landscape of ALS.

Payer considerations for providing access to genetic testing are explored by key opinion leaders.

Various approaches to genetic testing for ALS are explored.

Understanding how common genetic mutations in patients with ALS plays a role in prognosis.

The impact of genetic testing for ALS on a population health level.

Medical experts discuss genetically targeted treatments for patients diagnosed with ALS.

The unmet needs in ALS treatment management are explored.

In closing thoughts, the experts provide insight regarding the future of genetic testing in ALS treatment management.